As of: August 29, 2018
SYMBOL | DSCIX |
INCEPTION DATE | 11/2/15 |
BENCHMARK | Morningstar Small Core Index |
TOTAL FUND AUM | $12.61 MM |
TOTAL FIRM AUM | $6.5 BN |
MIN. INVESTMENT | $5,000 |
NET EXPENSE RATIO | 0.95% |
GROSS EXPENSE RATIO | 2.05% |
NUMBER OF HOLDINGS | 60 – 65 |
TARGET CASH POSITION | 0 – 1% |
INDIVIDUAL SECURITY LIMIT | < 4% |
SECTOR LIMITS | SECTOR NEUTRAL |
Data source: Morningstar Direct; The Adviser has contractually agreed to waive its management fee and/or reimburse certain operating expenses through 2/28/2023, so that Total Annual Operating Expenses does not exceed 0.95% for the Fund. Time period for statistical calculations is from fund inception to 6/30/22.
Horizon Therapeutics, PLC | 2.32% |
Pinnacle Financial Partners, Inc. | 2.24% |
Ensign Group, Inc. | 2.21% |
Clean Harbors, Inc. | 2.21% |
Cactus, Inc. Cl A | 2.16% |
Synovus Finnacial Corp. | 2.07% |
Regal Rexnord Corporation | 2.06% |
Ovintiv, Inc | 2.03% |
Simply Good Foods Co | 2.03% |
Chord Energy Corporation | 2.02% |